Alvaro Carvallo

1PUBLICATIONS
2CO-AUTHORS
Molecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (1)

|Nov 24, 2022
Fenebrutinib and BTK inhibition: Unveiling a new target for the treatment of chronic spontaneous urticaria.

Alvaro Carvallo, Sergio Sánchez-Fernández, María de la Paz Morales-Palacios

Pageof 1